Amedeo Smart

Free Medical Literature Service

 

Amedeo

Influenza
  Free Subscription

Articles published in
Epidemiol Infect
    April 2024
  1. CHAMBERS T, Anglemyer A, Chen A, Atkinson J, et al
    Population and contact tracer uptake of New Zealand's QR-code-based digital contact tracing app for COVID-19.
    Epidemiol Infect. 2024;152:e66.
    >> Share

  2. TSANG TK, Du RQR, Fang VJ, Lau EHY, et al
    Decreased risk of non-influenza respiratory infection after influenza B virus infection in children.
    Epidemiol Infect. 2024 Apr 8:1-21. doi: 10.1017/S0950268824000542.
    >> Share

    March 2024
  3. NESTERUK I
    Should we ignore SARS-CoV-2 disease?
    Epidemiol Infect. 2024;152:e57.
    >> Share

  4. PENG L, Huang X, Wang C, Xin H, et al
    Comparative epidemiology of outbreaks caused by SARS-CoV-2 Delta and Omicron variants in China.
    Epidemiol Infect. 2024;152:e43.
    >> Share

  5. MBOUSSOU F, Nkamedjie P, Oyaole D, Farham B, et al
    Rapid assessment of data systems for COVID-19 vaccination in the WHO African Region.
    Epidemiol Infect. 2024;152:e50.
    >> Share

  6. LOZANO D, Dohoo C, Elfstrom D, Carswell K, et al
    COVID-19 outbreak at a residential apartment building in Northern Ontario, Canada.
    Epidemiol Infect. 2024;152:e53.
    >> Share

    February 2024
  7. YAP WK, Attwell K
    Medical exemptions to mandatory vaccinations: The state of play in Australia and a pressure point to watch.
    Epidemiol Infect. 2024;152:e40.
    >> Share

  8. HOEG TB, Haslam A, Prasad V
    The importance of falsification endpoints in observational studies of vaccination to prevent severe disease: A critique of a harm-benefit analysis of BNT162b2 vaccination of 5- to 11-year-olds.
    Epidemiol Infect. 2024;152:e51.
    >> Share

  9. WAITE LL, Nahhas A, Irvahn J, Garden G, et al
    COVID-19 passenger screening to reduce travel risk and translocation of disease.
    Epidemiol Infect. 2024;152:e36.
    >> Share

  10. GARAY E, Whelan SPJ, DuBois RM, O'Rourke SM, et al
    Immune response to SARS-CoV-2 variants after immunization with different vaccines in Mexico.
    Epidemiol Infect. 2024;152:e30.
    >> Share

    January 2024
  11. YAMAYOSHI S, Nagai E, Mitamura K, Hagihara M, et al
    Seroprevalence of severe acute respiratory syndrome coronavirus 2 N antibodies between December 2021 and march 2023 in Japan.
    Epidemiol Infect. 2024;152:e24.
    >> Share

  12. BIRD O, Galiza EP, Baxter DN, Boffito M, et al
    The predictive role of symptoms in COVID-19 diagnostic models: A longitudinal insight.
    Epidemiol Infect. 2024;152:e37.
    >> Share

  13. ROSNER BM, Falkenhorst G, Kumpf I, Enssle M, et al
    Case-control study of behavioural and societal risk factors for sporadic SARS-CoV-2 infections, Germany, 2020-2021 (CoViRiS study).
    Epidemiol Infect. 2024;152:e16.
    >> Share

  14. SARKER P, Haq MA, Akhtar E, Roy AK, et al
    Serosurveillance among urban slum and non-slum populations immunized with COVID-19 vaccines in Bangladesh.
    Epidemiol Infect. 2024;152:e14.
    >> Share

  15. LIEPINS T, Davie G, Miller R, Whitehead J, et al
    Rural-urban variation in COVID-19 vaccination uptake in Aotearoa New Zealand: Examining the national roll-out.
    Epidemiol Infect. 2024;152:e7.
    >> Share

    December 2023
  16. SCHWARTZ RA, Suskind RM
    Post-COVID-19 neuropsychiatric manifestations: a suggested therapeutic approach to 'long COVID' with azithromycin.
    Epidemiol Infect. 2023;152:e34.
    >> Share

  17. PARRON I, Carol M, Bes N, Izquierdo C, et al
    The impact of COVID-19 pandemic on the incidence of acute gastroenteritis outbreaks in Catalonia (Spain).
    Epidemiol Infect. 2023;152:e10.
    >> Share

    November 2023
  18. ALEEM MA, Macintyre CR, Rahman B, Islam AKMM, et al
    Association of recent respiratory illness and influenza with acute myocardial infarction among the Bangladeshi population - a case-control study.
    Epidemiol Infect. 2023 Nov 30:1-38. doi: 10.1017/S0950268823001863.
    >> Share

  19. CHAVES-BLANCO L, de Salazar A, Fuentes A, Vinuela L, et al
    Evaluation of a combined detection of SARS-CoV-2 and its variants using real-time allele-specific PCR strategy: an advantage for clinical practice.
    Epidemiol Infect. 2023;151:e201.
    >> Share

  20. GULLE BT, Oren MM, Dal T
    COVID-19 vaccine hesitancy in Turkey: A systematic review and meta-analysis.
    Epidemiol Infect. 2023;151:e199.
    >> Share

  21. ELGERSMA IH, Fretheim A, Elstrom P, Aavitsland P, et al
    Association between face mask use and risk of SARS-CoV-2 infection: Cross-sectional study.
    Epidemiol Infect. 2023;151:e194.
    >> Share

  22. JIANG H, Gu Z, Liu H, Huang J, et al
    Evaluation of phase-adjusted interventions for COVID-19 using an improved SEIR model.
    Epidemiol Infect. 2023;152:e9.
    >> Share

  23. MERINO P, Kupferwasser D, Flores EA, Phan Tran D, et al
    Skin and soft tissue infection incidence before and during the COVID-19 pandemic.
    Epidemiol Infect. 2023;151:e190.
    >> Share

    October 2023
  24. SEGHEZZO G, Nash SG, Aziz NA, Hope R, et al
    Risk of severe outcomes among Omicron sub-lineages BA.4.6, BA.2.75, and BQ.1 compared to BA.5 in England.
    Epidemiol Infect. 2023;151:e189.
    >> Share

  25. DAVID JA, Kolipakkam B, Morales MK, Vissichelli NC, et al
    Cell-free plasma next-generation sequencing assists in the evaluation of secondary pneumonia in patients with COVID-19: a case series.
    Epidemiol Infect. 2023;151:e185.
    >> Share

  26. RODRIGUEZ-DEL-RIO FJ, Barroso P, Fernandez-de-Mera IG, de la Fuente J, et al
    COVID-19 epidemiology and rural healthcare: a survey in a Spanish village.
    Epidemiol Infect. 2023;151:e188.
    >> Share

  27. FLANNAGAN J, Chudasama DY, Hope R, Collin SM, et al
    Attribution of nosocomial seeding to long-term care facility COVID-19 outbreaks.
    Epidemiol Infect. 2023;151:e191.
    >> Share

  28. KIM JY, Lee WJ, Suh JW, Kim SB, et al
    Clinical impact of COVID-19 in patients with carbapenem-resistant Acinetobacter baumannii bacteraemia.
    Epidemiol Infect. 2023;151:e180.
    >> Share

  29. WONG R, Lovier MA
    Racial and ethnic disparities in COVID-19 diagnosis and adherence to mitigation behaviours in a national United States older adult sample.
    Epidemiol Infect. 2023;151:e175.
    >> Share

  30. CANELAS-FERNANDEZ J, Mazagatos C, Delgado-Sanz C, Larrauri A, et al
    Influenza hospitalizations in Spain between the last influenza and COVID-19 pandemics. 2009-2019.
    Epidemiol Infect. 2023 Oct 4:1-32. doi: 10.1017/S0950268823001620.
    >> Share

  31. ZHENG L, Qiu L, Wu L, Wang J, et al
    Association of SARS-CoV-2 viral load with abnormal laboratory characteristics and clinical outcomes in hospitalised COVID-19 patients.
    Epidemiol Infect. 2023;151:e173.
    >> Share

    September 2023
  32. GOPAL RAO G, Jinjika S, James D, Mukombe N, et al
    Nosocomial outbreak in a respiratory ward caused by the SARS-CoV-2 Omicron BA 5.2.1 subvariant associated with non-severe illness in vaccinated patients.
    Epidemiol Infect. 2023;151:e171.
    >> Share

  33. TWOHIG KA, Harman K, Zaidi A, Aliabadi S, et al
    Representativeness of whole-genome sequencing approaches in England: the importance for understanding inequalities associated with SARS-CoV-2 infection.
    Epidemiol Infect. 2023;151:e169.
    >> Share

  34. MITANGALA PN, Irenge LM, Musubao ET, Kahindo JBM, et al
    Prevalence of anti-SARS-CoV-2 antibodies in people attending the two main Goma markets in the eastern Democratic Republic of the Congo.
    Epidemiol Infect. 2023;151:e167.
    >> Share

  35. ZHAO T, Yang Z, Wu Y, Yang J, et al
    Immunogenicity and safety of COVID-19 vaccines among people living with HIV: A systematic review and meta-analysis.
    Epidemiol Infect. 2023;151:e176.
    >> Share

  36. NDZIESSI G, Niama RF, Aloumba AG, Peya JM, et al
    Seroprevalence of SARS-CoV-2 antibodies in Republic of Congo, February 2022.
    Epidemiol Infect. 2023;151:e162.
    >> Share

  37. MELLOR J, Overton CE, Fyles M, Chawner L, et al
    Understanding the leading indicators of hospital admissions from COVID-19 across successive waves in the UK.
    Epidemiol Infect. 2023;151:e172.
    >> Share

    August 2023
  38. GUHA SK, Sadhukhan S, Niyogi S
    COVID-19 cluster identification and support vector machine classifier model construction using global healthcare and socio-economic features.
    Epidemiol Infect. 2023;151:e159.
    >> Share

  39. GOLDSTEIN E
    Mortality associated with Omicron and influenza infections in France before and during the COVID-19 pandemic.
    Epidemiol Infect. 2023 Aug 25:1-22. doi: 10.1017/S0950268823001358.
    >> Share

  40. SZEKELY J, Rakchang W, Rattanaphan P, Kositpantawong N, et al
    Fluconazole and echinocandin resistance of Candida species in invasive candidiasis at a university hospital during pre-COVID-19 and the COVID-19 outbreak.
    Epidemiol Infect. 2023;151:e146.
    >> Share

  41. LOVE NK, Douglas A, Gharbia S, Hughes H, et al
    Understanding the impact of the COVID-19 pandemic response on GI infection surveillance trends in England, January 2020-April 2022.
    Epidemiol Infect. 2023;151:e147.
    >> Share

  42. JENNINGS S, Corrin T, Waddell L
    A systematic review of the evidence on the associations and safety of COVID-19 vaccination and post COVID-19 condition.
    Epidemiol Infect. 2023;151:e145.
    >> Share

  43. SATALA J, Wozniak A, Fabis M, Gorzelak-Pabis P, et al
    Severe COVID-19 classified by simple covid risk index is associated with higher levels of advanced oxidation protein products and 8-hydroxy 2 deoxyguanosine.
    Epidemiol Infect. 2023;151:e140.
    >> Share

  44. VERONESE G, Mahamid F, Bdier D
    Concerns, perceived risk, and hesitancy on COVID-19 vaccine: a qualitative exploration among university students living in the West Bank.
    Epidemiol Infect. 2023;151:e139.
    >> Share

    July 2023
  45. WALEKHWA AW, Nakazibwe B, Nantongo M, Wafula ST, et al
    COVID-19 second wave and clinical characteristics of cases in Uganda: A retrospective cross-sectional survey of confirmed SARS-CoV-2 cases, March-June 2021.
    Epidemiol Infect. 2023;151:e142.
    >> Share

  46. HALEVI A, Shkalim Zemer V, Embar T, Jacobson E, et al
    Attitudes toward COVID-19 vaccination of healthcare workers in Israel and vaccination rates during vaccine rollout.
    Epidemiol Infect. 2023;151:e132.
    >> Share

  47. DE CARVALHO FS, Slack SD, Barbosa-Junior F, de Campos MR, et al
    Genomic epidemiology of SARS-CoV-2 in large university hospital cohort: the UnCoVER-Brazil project.
    Epidemiol Infect. 2023;151:e126.
    >> Share

  48. FUNK T, Espenhain L, Moller FT, Ethelberg S, et al
    Factors associated with the formation of SARS-CoV-2 case-clusters in Danish schools: a nationwide register-based observational study.
    Epidemiol Infect. 2023;151:e168.
    >> Share

  49. GERRITZEN I, Brus IM, Spronk I, Biere-Rafi S, et al
    Identification of post-COVID-19 condition phenotypes, and differences in health-related quality of life and healthcare use: a cluster analysis.
    Epidemiol Infect. 2023;151:e123.
    >> Share

  50. BLACKBURN AM, Han H, Gallegos A
    Cross-language validation of COVID-19 Compliance Scale in 28 languages.
    Epidemiol Infect. 2023;151:e119.
    >> Share

  51. ROGERS JH, Cox SN, Link AC, Nwanne G, et al
    Incidence of SARS-CoV-2 infection and associated risk factors among staff and residents at homeless shelters in King County, Washington: an active surveillance study.
    Epidemiol Infect. 2023;151:e129.
    >> Share

  52. HADLEY L, Karachaliou Prasinou A, Christensen H, Ramsay M, et al
    Modelling the impact of COVID-19 and routine MenACWY vaccination on meningococcal carriage and disease in the UK - ERRATUM.
    Epidemiol Infect. 2023;151:e108.
    >> Share

  53. KULIMBET M, Saliev T, Alimbekova G, Ospanova D, et al
    Study of seroprevalence of SARS-CoV-2 in Kazakhstan.
    Epidemiol Infect. 2023;151:e116.
    >> Share

  54. RIEKKINEN M, Kajova M, Eriksson M, Luukkainen A, et al
    Superspreading of SARS-CoV-2 Omicron BA.2.23 among vaccinated Finnish adults: symptomatic COVID-19 only contracted by those without recent infection.
    Epidemiol Infect. 2023;151:e113.
    >> Share

  55. TOAN DTT, Pham TH, Nguyen KC, Pham QT, et al
    Shift from a Zero-COVID strategy to a New-normal strategy for controlling SARS-COV-2 infections in Vietnam.
    Epidemiol Infect. 2023;151:e117.
    >> Share

    June 2023
  56. GUO Y, Zeng X, Li L, Wang L, et al
    The impact of HBV infection on clinical outcomes of COVID-19 patients: a systematic review and meta-analysis.
    Epidemiol Infect. 2023;151:e135.
    >> Share

  57. LUO Y, Li Y, Xiao S, Lei H, et al
    Comparative analysis of inflight transmission of SARS-CoV-2, influenza, and SARS-CoV-1.
    Epidemiol Infect. 2023 Jun 23:1-22. doi: 10.1017/S0950268823001012.
    >> Share

  58. RAPTI I, Asimakopoulos A, Liontos A, Kosmidou M, et al
    Association of patient characteristics with clinical outcomes in a cohort of hospitalised patients with SARS-CoV-2 infection in a Greek referral centre for COVID-19 - Corrigendum.
    Epidemiol Infect. 2023;151:e91.
    >> Share

  59. LEOPARDI S, Desiato R, Mazzucato M, Orusa R, et al
    One health surveillance strategy for coronaviruses in Italian wildlife.
    Epidemiol Infect. 2023;151:e96.
    >> Share

  60. HADLEY L, Karachaliou Prasinou A, Christensen H, Ramsay M, et al
    Modelling the impact of COVID-19 and routine MenACWY vaccination on meningococcal carriage and disease in the UK.
    Epidemiol Infect. 2023;151:e98.
    >> Share

    May 2023
  61. HSU CY, Chen JK, Wikramaratna PS, Yen AM, et al
    Can ship travel contain COVID-19 outbreak after re-opening: a Bayesian meta-analysis.
    Epidemiol Infect. 2023;151:e99.
    >> Share

  62. SABIR QUA, Shafqat A, Aslam M
    Prediction of the COVID-19 transmission: a case study of Pakistan.
    Epidemiol Infect. 2023;151:e89.
    >> Share

  63. LUO E, Zhong Q, Wen Y, Cai J, et al
    Development and external validation of a prognostic tool for nonsevere COVID-19 inpatients.
    Epidemiol Infect. 2023;151:e128.
    >> Share

  64. CHANG H, Zhang X, Su H, Cai J, et al
    Epidemiological characteristics of paediatric Omicron infection during the outbreak of SARS-CoV-2 infection during March-May in 2022 in Shanghai, China.
    Epidemiol Infect. 2023;151:e81.
    >> Share

  65. SCHOEPS A, Walter J, Vogt M, Bent S, et al
    Direct and indirect vaccination effects on SARS-CoV-2 infection in day-care centres: Evaluating the policy for early vaccination of day-care staff in Germany, 2021.
    Epidemiol Infect. 2023;151:e80.
    >> Share

  66. SHI T, Huang L
    Prevalence of respiratory pathogens and risk of developing pneumonia under non-pharmaceutical interventions in Suzhou, China.
    Epidemiol Infect. 2023;151:e82.
    >> Share

    April 2023
  67. JOVANOVIC V, Milic M, Dotlic J, Cvjetkovic S, et al
    Mandatory and seasonal vaccination against COVID-19: Attitudes of the vaccinated people in Serbia.
    Epidemiol Infect. 2023;151:e83.
    >> Share

  68. FRILLI E, Amodeo D, Cevenini G, Nante N, et al
    Effectiveness of near-UVA in SARS-CoV-2 inactivation.
    Epidemiol Infect. 2023;151:e76.
    >> Share

  69. MERCKX J, Callies M, Kabouche I, Desombere I, et al
    SARS-CoV-2 seroprevalence and determinants for salivary seropositivity among pupils and school staff: a prospective cohort study.
    Epidemiol Infect. 2023;151:e75.
    >> Share

  70. WHITEHEAD J, Gan H, Heerikhuisen J, Gray G, et al
    Inequities in COVID-19 Omicron infections and hospitalisations for Maori and Pacific people in Te Manawa Taki Midland region, New Zealand.
    Epidemiol Infect. 2023;151:e74.
    >> Share

  71. ALHARBI B, Jennison AV, Hicks V, Whiley DM, et al
    Decreased Neisseria gonorrhoeae genotypic diversity following COVID-19 restrictions in Queensland, Australia 2020.
    Epidemiol Infect. 2023;151:e67.
    >> Share

  72. PRABHU VG, Hand WR, Isik T, Song Y, et al
    Risk-adjusted policies to minimise perioperative staffing shortages during a pandemic: An agent-based simulation study.
    Epidemiol Infect. 2023;151:e66.
    >> Share

  73. AHMED A, DeWitt ME, Dantuluri KL, Castri P, et al
    Characterisation of infection-induced SARS-CoV-2 seroprevalence amongst children and adolescents in North Carolina.
    Epidemiol Infect. 2023;151:e63.
    >> Share

    March 2023
  74. GOODWIN B, Zia H, Lo DF
    Assessment of early and post COVID-19 vaccination antibody response in healthcare workers: a critical review.
    Epidemiol Infect. 2023;151:e52.
    >> Share

  75. ALLEN H, Tessier E, Turner C, Anderson C, et al
    Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England.
    Epidemiol Infect. 2023;151:e58.
    >> Share

  76. MIZOUE T, Yamamoto S, Oshiro Y, Inamura N, et al
    Cumulative and undiagnosed SARS-CoV-2 infection among the staff of a medical research centre in Tokyo after the emergence of variants.
    Epidemiol Infect. 2023;151:e48.
    >> Share

    February 2023
  77. CAPELASTEGUI F, Flannagan J, Augarde E, Tessier E, et al
    Making the invisible visible: using national surveillance data to identify people experiencing homelessness in England with COVID-19.
    Epidemiol Infect. 2023;151:e51.
    >> Share

  78. SALAMA M, Amitai Z, Sheffer R
    Demographic and clinical characteristics of children and adolescents hospitalised with laboratory-confirmed COVID-19 in the Tel-Aviv District, Israel, 2020-2022.
    Epidemiol Infect. 2023;151:e42.
    >> Share

  79. ZHOU Y, Li Z, Wu W, Xiao J, et al
    Transmission trends of the global COVID-19 pandemic with combined effects of adaptive behaviours and vaccination.
    Epidemiol Infect. 2023;151:e39.
    >> Share

  80. HU CY, Lei Y, Tang YW, Cui WS, et al
    Characteristics of patients with SARS-COV-2 PCR re-positivity after recovering from COVID-19.
    Epidemiol Infect. 2023;151:e34.
    >> Share

  81. MAIER BF, Rose AH, Burdinski A, Klamser P, et al
    Estimating the share of SARS-CoV-2-immunologically naive individuals in Germany up to June 2022.
    Epidemiol Infect. 2023;151:e38.
    >> Share

  82. HALL RN, Jones A, Crean E, Marriott V, et al
    Public health interventions successfully mitigated multiple incursions of SARS-CoV-2 Delta variant in the Australian Capital Territory.
    Epidemiol Infect. 2023;151:e30.
    >> Share

  83. TAYLOR MJ, Kumbang J, Bamford K, Mohammed Jazuli Ismail H, et al
    A SARS-CoV-2 outbreak associated with five air force bases and a nightclub following the lifting of COVID-19-related social restrictions, United Kingdom, July-to-September 2021.
    Epidemiol Infect. 2023;151:e26.
    >> Share

  84. IRENGE LM, Bulakali HM, Akonkwa AI, Ambroise J, et al
    Seroprevalence of COVID-19 infection in a densely populated district in the eastern Democratic Republic of Congo.
    Epidemiol Infect. 2023;151:e24.
    >> Share

  85. NAUTA M, McManus O, Traeholt Franck K, Lindberg Marving E, et al
    Early detection of local SARS-CoV-2 outbreaks by wastewater surveillance: a feasibility study.
    Epidemiol Infect. 2023;151:e28.
    >> Share

    January 2023
  86. GORI M, Fappani C, Bianchi S, Canuti M, et al
    A large A(H3N2) influenza outbreak with a high attack rate in a drug user community in Italy, April 2022.
    Epidemiol Infect. 2023 Jan 19:1-13. doi: 10.1017/S0950268823000055.
    >> Share

  87. SALMONSMITH J, Ducci A, Balachandran R, Guo L, et al
    Use of portable air purifiers to reduce aerosols in hospital settings and cut down the clinical backlog.
    Epidemiol Infect. 2023;151:e21.
    >> Share

  88. ABOU HASSAN FF, Bou Hamdan M, Ali F, Melhem NM, et al
    Response to COVID-19 in Lebanon: update, challenges and lessons learned.
    Epidemiol Infect. 2023;151:e23.
    >> Share

  89. MANSOUR GHANAIE R, Jamee M, Khodaei H, Shirvani A, et al
    Assessment of early and post COVID-19 vaccination antibody response in healthcare workers: a multicentre cross-sectional study on inactivated, mRNA and vector-based vaccines.
    Epidemiol Infect. 2023;151:e12.
    >> Share

  90. GORELIK Y, Dror A, Zayyad H, Wertheim O, et al
    Associations between reported post-COVID-19 symptoms and subjective well-being, Israel, July 2021 - April 2022.
    Epidemiol Infect. 2023;151:e16.
    >> Share

    December 2022
  91. ROY DN, Azam MS, Biswas M, Islam E, et al
    Potential factors influencing COVID-19 vaccine acceptance and hesitancy among university students in Bangladesh: a cross-sectional comparative study.
    Epidemiol Infect. 2022;151:e11.
    >> Share

  92. WARD T, Glaser A, Overton CE, Carpenter B, et al
    Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.
    Epidemiol Infect. 2022;151:e32.
    >> Share

  93. MANICA M, Litvinova M, De Bellis A, Guzzetta G, et al
    Estimation of the incubation period and generation time of SARS-CoV-2 Alpha and Delta variants from contact tracing data.
    Epidemiol Infect. 2022;151:e5.
    >> Share

  94. WADE D, Ashton-Butt A, Scott G, Reid SM, et al
    High pathogenicity avian influenza: Targeted active surveillance of wild birds to enable early detection of emerging disease threats.
    Epidemiol Infect. 2022 Dec 11:1-29. doi: 10.1017/S0950268822001856.
    >> Share

  95. HOSKINS S, Beale S, Nguyen V, Boukari Y, et al
    Relative contribution of essential and non-essential activities to SARS-CoV-2 transmission following the lifting of public health restrictions in England and Wales.
    Epidemiol Infect. 2022;151:e3.
    >> Share

  96. GASPERINI B, Sarti D, Rondina T, Moretti M, et al
    COVID-19 isolation/quarantine rules in home care patients.
    Epidemiol Infect. 2022;150:e206.
    >> Share

    November 2022
  97. BHUIYAN MS, Brintz BJ, Whitcombe AL, Markmann AJ, et al
    Combining antibody markers for serosurveillance of SARS-CoV-2 to estimate seroprevalence and time-since-infection - CORRIGENDUM.
    Epidemiol Infect. 2022;150:e188.
    >> Share

  98. PANDEY BD, Ngwe Tun MM, Pandey K, Dumre SP, et al
    Has COVID-19 suppressed dengue transmission in Nepal?
    Epidemiol Infect. 2022;150:e196.
    >> Share

  99. BEEBEEJAUN K, Pebody R, Ciobanu S, Pukkila J, et al
    UEFA Euro 2020: lessons from the first multi-city international mass gathering during the COVID-19 pandemic.
    Epidemiol Infect. 2022;150:e182.
    >> Share

  100. HEIJMINK L, Tonis J, Gilhuis N, Gerkema M, et al
    Epidemiological evaluation of mass testing in a small municipality in the Netherlands during the SARS-CoV-2 epidemic.
    Epidemiol Infect. 2022;150:e193.
    >> Share

  101. MIYAMA T, Jung SM, Nishiura H
    Decrease in overdispersed secondary transmission of COVID-19 over time in Japan.
    Epidemiol Infect. 2022;150:e197.
    >> Share

  102. MCGRATH J, McAloon CG, More SJ, Garrett S, et al
    Risk factors for SARS-CoV-2 infection in healthcare workers following an identified nosocomial COVID-19 exposure during waves 1-3 of the pandemic in Ireland.
    Epidemiol Infect. 2022;150:e186.
    >> Share

  103. LEE YH, Choe YJ, Lee H, Choi EH, et al
    Spatial distribution of SARS-CoV-2 infection in schools, South Korea.
    Epidemiol Infect. 2022;150:e194.
    >> Share

  104. LE GLASS E, Raoult D, Dubourg G
    Snapshot of COVID-19 superinfections in Marseille hospitals: where are the common pathogens?
    Epidemiol Infect. 2022;150:e195.
    >> Share

  105. VALLEE A
    Underestimation of the number of COVID-19 cases, an epidemiological threat.
    Epidemiol Infect. 2022;150:e191.
    >> Share

  106. LIM WW, Cowling BJ, Nakafero G, Feng S, et al
    The impact of repeated vaccination on relative influenza vaccine effectiveness among vaccinated adults in the United Kingdom.
    Epidemiol Infect. 2022 Nov 4:1-30. doi: 10.1017/S0950268822001753.
    >> Share

  107. BLAKEY E, Reeve L, Verlander NQ, Edwards D, et al
    Social risk factors for SARS-CoV-2 acquisition in university students: cross sectional survey.
    Epidemiol Infect. 2022;150:e201.
    >> Share

  108. TSUZUKI S, Akiyama T, Matsunaga N, Ohmagari N, et al
    Association between physical activity status and severity of COVID-19 in older adults.
    Epidemiol Infect. 2022;150:e189.
    >> Share

  109. EBERHARDT AT, Simoncini M, Pina C, Galoppo G, et al
    Preceding anti-spike IgG levels predicted risk and severity of COVID-19 during the Omicron-dominant wave in Santa Fe city, Argentina.
    Epidemiol Infect. 2022;150:e187.
    >> Share

    October 2022
  110. GOLDSTEIN E, Fireman BH, Klein NP, Lipsitch M, et al
    Prescribing for different antibiotic classes across age groups in the Kaiser Permanente Northern California population in association with influenza incidence, 2010-2018.
    Epidemiol Infect. 2022 Oct 26:1-30. doi: 10.1017/S0950268822001662.
    >> Share

  111. NOMOTO H, Asai Y, Hayakawa K, Matsunaga N, et al
    Impact of the COVID-19 pandemic on racial and ethnic minorities in Japan.
    Epidemiol Infect. 2022;150:e202.
    >> Share

  112. FILIPPATOS F, Tatsi EB, Dellis C, Koukou DM, et al
    SARS-CoV-2 seroepidemiology in paediatric population during Delta and Omicron predominance.
    Epidemiol Infect. 2022;150:e177.
    >> Share

  113. MAMISHI S, Olfat M, Pourakbari B, Eshaghi H, et al
    Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in children: update and new insights from the second report of an Iranian referral hospital.
    Epidemiol Infect. 2022;150:e179.
    >> Share

  114. WRIGHT E, Pollard G, Robertson H, Anuradha S, et al
    Household transmission of the Delta COVID-19 variant in Queensland, Australia: a case series.
    Epidemiol Infect. 2022;150:e173.
    >> Share

    September 2022
  115. TAN J, Ge Y, Martinez L, Sun J, et al
    Transmission roles of symptomatic and asymptomatic COVID-19 cases: a modelling study.
    Epidemiol Infect. 2022;150:e171.
    >> Share

  116. ZHOU N, Dai H, Zha W, Lv Y, et al
    The impact of meteorological factors and PM2.5 on COVID-19 transmission - CORRIGENDUM.
    Epidemiol Infect. 2022;150:e164.
    >> Share

  117. HAN H, Blackburn AM, Jeftic A, Tran TP, et al
    Validity testing of the conspiratorial thinking and anti-expert sentiment scales during the COVID-19 pandemic across 24 languages from a large-scale global dataset.
    Epidemiol Infect. 2022;150:e167.
    >> Share

  118. MAGAZZINO C, Mele M, Coccia M
    A machine learning algorithm to analyse the effects of vaccination on COVID-19 mortality.
    Epidemiol Infect. 2022;150:e168.
    >> Share

    August 2022
  119. CHEN CWS, So MKP, Liu FC
    Assessing government policies' impact on the COVID-19 pandemic and elderly deaths in East Asia.
    Epidemiol Infect. 2022;150:e161.
    >> Share

  120. EKROTH AKE, Patrzylas P, Turner C, Hughes GJ, et al
    Comparative symptomatology of infection with SARS-CoV-2 variants Omicron (B.1.1.529) and Delta (B.1.617.2) from routine contact tracing data in England.
    Epidemiol Infect. 2022;150:e162.
    >> Share

  121. BAYS D, Bennett E, Finnie T
    What effect might border screening have on preventing importation of COVID-19 compared with other infections?: considering the additional effect of post-arrival isolation.
    Epidemiol Infect. 2022;150:e159.
    >> Share

  122. PAGEN DME, Brinkhues S, Dukers-Muijrers NHTM, den Heijer CDJ, et al
    Sex and age differences in the proportion of experienced symptoms by SARS-CoV-2 serostatus in a community-based cross-sectional study.
    Epidemiol Infect. 2022;150:e157.
    >> Share

  123. BUCHHOLZ U, An der Heiden M
    Serial interval in households infected with SARS-CoV-2 variant B.1.1.529 (Omicron) are even shorter compared to Delta.
    Epidemiol Infect. 2022 Aug 5:1-5. doi: 10.1017/S0950268822001248.
    >> Share

    July 2022
  124. NIELSEN RT, Dalby T, Emborg HD, Larsen AR, et al
    COVID-19 preventive measures coincided with a marked decline in other infectious diseases in Denmark, spring 2020.
    Epidemiol Infect. 2022;150:e138.
    >> Share

  125. AL-SHEHARI WA, Yin YA, Wang X, Wang Y, et al
    Prevalence and surveillance of tuberculosis in Yemen from 2006 to 2018.
    Epidemiol Infect. 2022;150:e146.
    >> Share

  126. SMALLMAN-RAYNOR MR, Cliff AD
    Spatial growth rate of emerging SARS-CoV-2 lineages in England, September 2020-December 2021.
    Epidemiol Infect. 2022;150:e145.
    >> Share

  127. PRICE O, Birrell FA, Mifsud EJ, Sullivan SG, et al
    Epidemiology of repeat influenza infection in Queensland, Australia, 2005-2017.
    Epidemiol Infect. 2022 Jul 18:1-19. doi: 10.1017/S0950268822001157.
    >> Share

  128. SILVA MJA, Rodrigues YC, Lima KVB, Lima LNGC, et al
    Innate immunity to SARS-CoV-2 infection: a review.
    Epidemiol Infect. 2022;150:e142.
    >> Share

  129. IMPOUMA B, Mboussou F, Farham B, Makubalo L, et al
    COVID-19 vaccination rollout in the World Health Organization African region: status at end June 2022 and way forward.
    Epidemiol Infect. 2022;150:e143.
    >> Share

  130. JANNUZZI P, Panza GA
    Author response to: Letter to Editor in Response to the association between contact with children and the clinical course of COVID-19.
    Epidemiol Infect. 2022;150:e139.
    >> Share

  131. LOSS J, Wurm J, Varnaccia G, Schienkiewitz A, et al
    Transmission of SARS-CoV-2 among children and staff in German daycare centres.
    Epidemiol Infect. 2022;150:e141.
    >> Share

  132. AUSTHOF E, Bell ML, Riddle MS, Catalfamo C, et al
    Persisting gastrointestinal symptoms and post-infectious irritable bowel syndrome following SARS-CoV-2 infection: results from the Arizona CoVHORT.
    Epidemiol Infect. 2022 Jul 8:1-22. doi: 10.1017/S0950268822001200.
    >> Share

  133. SOYEMI E, Soyemi K
    Response to the association between contact with children and the clinical course of COVID-19.
    Epidemiol Infect. 2022;150:e140.
    >> Share

    June 2022
  134. DE MARCO VERISSIMO C, Lopez Corrales J, Dorey AL, Cwiklinski K, et al
    Production of a functionally active recombinant SARS-CoV-2 (COVID-19) 3C-like protease and a soluble inactive 3C-like protease-RBD chimeric in a prokaryotic expression system.
    Epidemiol Infect. 2022;150:e128.
    >> Share

  135. JUDSON SD, Torimiro J, Pigott DM, Maima A, et al
    COVID-19 data reporting systems in Africa reveal insights for future pandemics.
    Epidemiol Infect. 2022;150:e119.
    >> Share

  136. DEN BOOGERT EM, de Lange MMA, Wielders CCH, Rietveld A, et al
    Incidence and severity of SARS-CoV-2 infection in former Q fever patients as compared to the Dutch population, 2020-2021.
    Epidemiol Infect. 2022;150:e116.
    >> Share

    May 2022
  137. ADAMSON JP, Smith C, Pacchiarini N, Connor TR, et al
    A large outbreak of COVID-19 in a UK prison, October 2020 to April 2021.
    Epidemiol Infect. 2022;150:e134.
    >> Share

  138. RAY I, Hasan MM, Shah PA, Sahito AM, et al
    HIV epidemic amidst COVID-19 pandemic in India: a conundrum for the country's healthcare system.
    Epidemiol Infect. 2022;150:e112.
    >> Share

  139. XU X, Zhang K, Ma H, Shen X, et al
    Differences in service and antibiotics use following symptomatic respiratory tract infections between 2016 and 2021 in rural Anhui, China.
    Epidemiol Infect. 2022;150:e117.
    >> Share

  140. LACY J, Mensah A, Simmons R, Andrews N, et al
    Protective effect of a first SARS-CoV-2 infection from reinfection: a matched retrospective cohort study using PCR testing data in England.
    Epidemiol Infect. 2022;150:e109.
    >> Share

  141. PARROTT JC, Annibale AM, Osahan S, Alroy K, et al
    Prevalence of SARS-CoV-2 antibodies during phased access to vaccination: results from a population-based survey in New York City, September 2020-March 2021.
    Epidemiol Infect. 2022;150:e105.
    >> Share

  142. EDELMAN NL, Simon P, Cassell JA, Kiss IZ, et al
    Network analysis of England's single parent household COVID-19 control policy impact: a proof-of-concept study.
    Epidemiol Infect. 2022;150:e104.
    >> Share

  143. LONG H, Li J, Li R, Zhang H, et al
    Plasma glucose levels and diabetes are independent predictors for mortality in patients with COVID-19.
    Epidemiol Infect. 2022;150:e106.
    >> Share

  144. SHINGLETON J, Finnie T, Gent N, Bennett E, et al
    Assessing the role of imported cases on the establishment of SARS-CoV-2 Delta variant of concern in Bolton, UK.
    Epidemiol Infect. 2022;150:e100.
    >> Share

  145. HIIRONEN I, Saavedra-Campos M, Panitz J, Ma T, et al
    Workplace exposures associated with COVID-19: evidence from a case-control study with multiple sampling periods in England, August-October 2020.
    Epidemiol Infect. 2022;150:e99.
    >> Share

  146. THOMAS DR, Fina LH, Adamson JP, Sawyer C, et al
    Social, demographic and behavioural determinants of SARS-CoV-2 infection: a case-control study carried out during mass community testing of asymptomatic individuals in South Wales, December 2020.
    Epidemiol Infect. 2022;150:e115.
    >> Share

  147. POKUTNAYA D, Loiacono MM, Booth H, Williams R, et al
    The impact of clinical risk conditions on influenza and pneumonia diagnoses in England: a nationally-representative retrospective cohort study, 2010-2019.
    Epidemiol Infect. 2022 May 6:1-24. doi: 10.1017/S0950268822000838.
    >> Share

    April 2022
  148. WONG JY, Cheung CM, Bond HS, Cheung JK, et al
    Estimating excess septicaemia mortality and hospitalisation burden associated with influenza in Hong Kong, 1998 to 2019.
    Epidemiol Infect. 2022;150:e101.
    >> Share

  149. FABRICIUS G, Borzi RA, Caminos J, Grigera TS, et al
    Immunity acquired by a minority active fraction of the population could explain COVID-19 spread in Greater Buenos Aires (June-November 2020).
    Epidemiol Infect. 2022;150:e84.
    >> Share

  150. RICCARDO F, Frisicale EM, Guzzetta G, Ferraro F, et al
    Winning during a pandemic: epidemiology of SARS-CoV-2 during EURO2020 in Italy.
    Epidemiol Infect. 2022;150:e166.
    >> Share

    March 2022
  151. SCHULMAN A, Bhanot G
    Using postal change-of-address data to predict second waves in infections near pandemic epicentres.
    Epidemiol Infect. 2022;150:e120.
    >> Share

  152. BENNEDBAEK M, Button MSF, Nielsen LB, Bybjerg-Grauholm J, et al
    Increased transmission of SARS-CoV-2 in Denmark during UEFA European championships.
    Epidemiol Infect. 2022;150:e123.
    >> Share

  153. SARVIKIVI E, Salminen M, Savolainen-Kopra C, Ikonen N, et al
    COVID-19 cases in spectators returning to Finland from UEFA Euro 2020 matches in Saint Petersburg.
    Epidemiol Infect. 2022;150:e121.
    >> Share

  154. DASH P, Mansingh A, Nayak SR, Sahoo D, et al
    Infection, cases due to SARS-CoV-2 in rural areas during early COVID-19 vaccination: findings from serosurvey study in a rural cohort of eastern India.
    Epidemiol Infect. 2022;150:e58.
    >> Share

  155. HUANG Z, Guo H, Lim HY, Chow A, et al
    Determinants of the acceptance and adoption of a digital contact tracing tool during the COVID-19 pandemic in Singapore.
    Epidemiol Infect. 2022;150:e54.
    >> Share

    February 2022
  156. GOLDSTEIN E, Fireman BH, Klein NP, Lipsitch M, et al
    Antibiotic prescribing across age groups in the Kaiser Permanente Northern California population in association with different diagnoses, and with influenza incidence, 2010-2018.
    Epidemiol Infect. 2022;150:e85.
    >> Share

  157. AWAN HA, Sahito AM, Sukaina M, Khatri G, et al
    Tuberculosis amidst COVID-19 in Pakistan: a massive threat of overlapping crises for the fragile healthcare systems.
    Epidemiol Infect. 2022;150:e41.
    >> Share

  158. PECKEU-ABBOUD L, van Kleef E, Smekens T, Latour K, et al
    Factors influencing SARS-CoV-2 infection rate in Belgian nursing home residents during the first wave of COVID-19 pandemic.
    Epidemiol Infect. 2022;150:e72.
    >> Share

  159. YUN KW, Kim YK, Song ES, An HY, et al
    Outbreak of COVID-19 among children and young adults in a cancer centre daycare unit.
    Epidemiol Infect. 2022;150:e40.
    >> Share

  160. CORDIOLI M, Mirandola M, Gios L, Gaspari S, et al
    COVID-19 seroprevalence amongst healthcare workers: potential biases in estimating infection prevalence.
    Epidemiol Infect. 2022;150:e48.
    >> Share

  161. HEINZINGER S, Eberle U, Angermeier H, Flechsler J, et al
    Reciprocal circulation pattern of SARS-CoV-2 and influenza viruses during the influenza seasons 2019/2020 and 2020/2021 in the Bavarian Influenza Sentinel (Germany) - CORRIGENDUM.
    Epidemiol Infect. 2022;150:e24.
    >> Share

  162. BROOKES SM, Mansfield KL, Reid SM, Coward V, et al
    Incursion of H5N8 High Pathogenicity Avian Influenza Virus (HPAIV) into Gamebirds in England.
    Epidemiol Infect. 2022 Feb 10:1-36. doi: 10.1017/S0950268821002740.
    >> Share

  163. POMEROY MA, Hoover ER, Dumas BL, Kennedy KS, et al
    Decisions to attend holiday gatherings during COVID-19 and engagement in key prevention strategies: United States, January 2021.
    Epidemiol Infect. 2022;150:e32.
    >> Share

  164. SEVINC SA, Metin S, Basi NB, Ling J, et al
    Effectiveness of inactivated SARS-CoV-2 vaccine (CoronaVac) on intensive care unit survival.
    Epidemiol Infect. 2022;150:e35.
    >> Share

  165. HAN H
    Trust in the scientific research community predicts intent to comply with COVID-19 prevention measures: An analysis of a large-scale international survey dataset.
    Epidemiol Infect. 2022;150:e36.
    >> Share

  166. NA'AMNIH W, Kassem E, Tannous S, Kagan V, et al
    Incidence and risk factors of hospitalisations for respiratory syncytial virus among children aged less than 2 years.
    Epidemiol Infect. 2022;150:e45.
    >> Share

    January 2022
  167. SMITH JAE, Hopkins S, Turner C, Dack K, et al
    Public health impact of mass sporting and cultural events in a rising COVID-19 prevalence in England.
    Epidemiol Infect. 2022;150:e42.
    >> Share

  168. KASSIE A, Handebo S, Adugna A, Shitu K, et al
    Violence against girls during COVID-19 pandemic and associated factors in Gondar city, North West Ethiopia.
    Epidemiol Infect. 2022;150:e31.
    >> Share

  169. LIU F, Zhao Z, Ma C, Nie X, et al
    Return to normal pre-COVID-19 life is delayed by inequitable vaccine allocation and SARS-CoV-2 variants.
    Epidemiol Infect. 2022;150:e46.
    >> Share

  170. ZHOU N, Dai H, Zha W, Lv Y, et al
    The impact of meteorological factors and PM2.5 on COVID-19 transmission.
    Epidemiol Infect. 2022;150:e38.
    >> Share

  171. SPAHN C, Hipp AM, Richter B, Nusseck M, et al
    Coronavirus vaccination rates in cultural areas in Germany.
    Epidemiol Infect. 2022;150:e34.
    >> Share

  172. DECUIR J, Baggs J, Melgar M, Patel P, et al
    Identification and description of patients with multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection using the Premier Healthcare Database.
    Epidemiol Infect. 2022;150:e26.
    >> Share

  173. ESKILD A, Morkrid L, Mortensen SB, Leegaard TM, et al
    Prevalence of antibodies against SARS-CoV-2 among pregnant women in Norway during the period December 2019 through December 2020.
    Epidemiol Infect. 2022;150:e28.
    >> Share

  174. LIM C, Nam Y, Oh WS, Ham S, et al
    Characteristics of transmission routes of COVID-19 cluster infections in Gangwon Province, Korea.
    Epidemiol Infect. 2022;150:e19.
    >> Share

  175. BHUIYAN MS, Brintz BJ, Whitcombe AL, Markmann AJ, et al
    Combining antibody markers for serosurveillance of SARS-CoV-2 to estimate seroprevalence and time-since-infection.
    Epidemiol Infect. 2022;150:e20.
    >> Share

  176. CAVANY S, Bivins A, Wu Z, North D, et al
    Inferring SARS-CoV-2 RNA shedding into wastewater relative to the time of infection.
    Epidemiol Infect. 2022;150:e21.
    >> Share

    December 2021
  177. NOAH N, Edelstein M
    African COVID-19 special issue introduction.
    Epidemiol Infect. 2021;149:e257.
    >> Share

  178. SCHOOLING CM, Li M, Au Yeung SL
    Interleukin-18 and COVID-19.
    Epidemiol Infect. 2021;150:e14.
    >> Share

  179. TSUZUKI S, Ohmagari N, Beutels P
    The burden of isolation to the individual: a comparison between isolation for COVID-19 and for other influenza-like illnesses in Japan.
    Epidemiol Infect. 2021;150:e5.
    >> Share

  180. MUGHINI-GRAS L, Chaname Pinedo L, Pijnacker R, van den Beld M, et al
    Impact of the COVID-19 pandemic on human salmonellosis in the Netherlands.
    Epidemiol Infect. 2021;149:e254.
    >> Share

    November 2021
  181. ALJOHANI NI, Mutai K
    Effect of non-pharmacological interventions on the COVID-19 epidemic in Saudi Arabia.
    Epidemiol Infect. 2021;149:e252.
    >> Share

  182. MUNCH PK, Espenhain L, Hansen CH, Muller L, et al
    Societal activities associated with SARS-CoV-2 infection: a case-control study in Denmark, November 2020.
    Epidemiol Infect. 2021;150:e9.
    >> Share

  183. MAGAZZINO C, Mele M, Schneider N
    Assessing a fossil fuels externality with a new neural networks and image optimisation algorithm: the case of atmospheric pollutants as confounders to COVID-19 lethality.
    Epidemiol Infect. 2021;150:e1.
    >> Share

  184. LAI J, Hughes HE, Morbey R, Loveridge P, et al
    Developing a sentinel syndromic surveillance system using school-absenteeism data, example monitoring absences over the 2020 COVID-19 pandemic.
    Epidemiol Infect. 2021;149:e248.
    >> Share

  185. TATSI EB, Filippatos F, Michos A
    SARS-CoV-2 variants and effectiveness of vaccines: a review of current evidence.
    Epidemiol Infect. 2021;149:e237.
    >> Share

  186. BAYS D, Bennett E, Finnie T
    What effect might border screening have on preventing the importation of COVID-19 compared with other infections? A modelling study.
    Epidemiol Infect. 2021;149:e238.
    >> Share

  187. IMPOUMA B, Mboussou F, Shahpar C, Wolfe CM, et al
    Estimating the SARS-CoV2 infections detection rate and cumulative incidence in the World Health Organization African Region 10 months into the pandemic.
    Epidemiol Infect. 2021;149:e264.
    >> Share

  188. IMPOUMA B, Mboussou F, Farham B, Wolfe CM, et al
    The COVID-19 pandemic in the WHO African region: the first year (February 2020 to February 2021).
    Epidemiol Infect. 2021;149:e263.
    >> Share

  189. LI R, Li Q, Liu Y, Shen M, et al
    Modelling the impact of universal influenza vaccines on seasonal influenza with different subtypes.
    Epidemiol Infect. 2021;149:e253.
    >> Share

    October 2021
  190. NICHOLS M, Gollarza L, Palacios A, Stapleton GS, et al
    Salmonella illness outbreaks linked to backyard poultry purchasing during the COVID-19 pandemic: United States, 2020.
    Epidemiol Infect. 2021;149:e234.
    >> Share

  191. JUUTINEN A, Sarvikivi E, Laukkanen-Nevala P, Helve O, et al
    Closing lower secondary schools had no impact on COVID-19 incidence in 13-15-year-olds in Finland.
    Epidemiol Infect. 2021;149:e233.
    >> Share

  192. HEINZINGER S, Eberle U, Angermeier H, Flechsler J, et al
    Reciprocal circulation pattern of SARS-CoV-2 and influenza viruses during the influenza seasons 2019/2020 and 2020/2021 in the Bavarian Influenza Sentinel (Germany).
    Epidemiol Infect. 2021;149:e226.
    >> Share

  193. MANCILLA-GALINDO J, Kammar-Garcia A, Martinez-Esteban A, Meza-Comparan HD, et al
    COVID-19 patients with increasing age experience differential time to initial medical care and severity of symptoms.
    Epidemiol Infect. 2021;149:e230.
    >> Share

  194. GONZALEZ F, Vielot NA, Sciaudone M, Toval-Ruiz C, et al
    Seroepidemiology of SARS-CoV-2 infections in an urban population-based cohort in Leon, Nicaragua.
    Epidemiol Infect. 2021;149:e247.
    >> Share

  195. AEMRO A, Amare NS, Shetie B, Chekol B, et al
    Determinants of COVID-19 vaccine hesitancy among health care workers in Amhara region referral hospitals, Northwest Ethiopia: a cross-sectional study.
    Epidemiol Infect. 2021;149:e225.
    >> Share

  196. SINGH C, Naik BN, Pandey S, Biswas B, et al
    Effectiveness of COVID-19 vaccine in preventing infection and disease severity: a case-control study from an Eastern State of India.
    Epidemiol Infect. 2021;149:e224.
    >> Share

  197. ZHAO X, Shen Z, Sun L, Cheng L, et al
    A network meta-analysis of secondary attack rates of COVID-19 in different contact environments.
    Epidemiol Infect. 2021;149:e219.
    >> Share

    September 2021
  198. KEITA MB, Pierre F, Ndjomou J, Traore B, et al
    The first epidemiological and virological influenza surveillance in the Republic of Guinea revealed the predominance of influenza A/H3N2 and B Victoria viruses.
    Epidemiol Infect. 2021 Sep 28:1-20. doi: 10.1017/S0950268821001965.
    >> Share

  199. SCHOEPS A, Hoffmann D, Tamm C, Vollmer B, et al
    Surveillance of SARS-CoV-2 transmission in educational institutions, August to December 2020, Germany.
    Epidemiol Infect. 2021;149:e213.
    >> Share

  200. CHENG X, Li Y, Zhang Y, Lu J, et al
    The characteristics of and responses to the two COVID-19 outbreak waves in Hebei Province of China, January 2020 to February 2021.
    Epidemiol Infect. 2021;149:e212.
    >> Share

  201. AKTAS YILDIRIM S, Sarikaya ZT, Ulugol H, Ozata S, et al
    Are surgical and non-operating room intervention safe in the COVID-19 pandemic? A retrospective study.
    Epidemiol Infect. 2021;149:e210.
    >> Share

  202. GOLDENFELD M, Zuckerman N, Amit S, Tal I, et al
    First reported nosocomial SARS-CoV-2 outbreak in a hospital-based laundry facility.
    Epidemiol Infect. 2021;150:e18.
    >> Share

  203. MUSA OAH, Chivese T, Bansal D, Abdulmajeed J, et al
    Prevalence and determinants of symptomatic COVID-19 infection among children and adolescents in Qatar: a cross-sectional analysis of 11 445 individuals.
    Epidemiol Infect. 2021;149:e203.
    >> Share

  204. SPINICCI M, Pengue L, Bartolozzi D, Quercioli M, et al
    Soccer in the time of COVID-19: 1 year report from an Italian top league club, March 2020-February 2021.
    Epidemiol Infect. 2021;149:e207.
    >> Share

  205. IMPOUMA B, Williams GS, Moussana F, Mboussou F, et al
    The first 8 months of COVID-19 pandemic in three West African countries: leveraging lessons learned from responses to the 2014-2016 Ebola virus disease outbreak.
    Epidemiol Infect. 2021;149:e258.
    >> Share

    August 2021
  206. ABU JABAL K, Ben-Amram H, Beiruti K, Brimat I, et al
    SARS-CoV-2 immunogenicity in individuals infected before and after COVID-19 vaccination: Israel, January-March 2021.
    Epidemiol Infect. 2021;149:e239.
    >> Share

  207. MBOUSSOU F, Impouma B, Farham B, Wolfe CM, et al
    Analysing the reported incidence of COVID-19 and factors associated in the World Health Organization African region as of 31 December 2020.
    Epidemiol Infect. 2021;149:e256.
    >> Share

  208. ALPCAN A, Tursun S, Kandur Y
    Vitamin D levels in children with COVID-19: a report from Turkey.
    Epidemiol Infect. 2021;149:e180.
    >> Share

  209. NAESENS R, Mertes H, Clukers J, Herzog S, et al
    SARS-CoV-2 seroprevalence survey among health care providers in a Belgian public multiple-site hospital.
    Epidemiol Infect. 2021;149:e172.
    >> Share

  210. BAUMEISTER A, Corrin T, Abid H, Young KM, et al
    The quality of systematic reviews and other synthesis in the time of COVID-19.
    Epidemiol Infect. 2021;149:e182.
    >> Share

  211. CHENG CH, Chow CL, Chow WK
    A discussion on the minimum required number of tests in two common pooling test methods for SARS-CoV-2.
    Epidemiol Infect. 2021;149:e179.
    >> Share

  212. MELOTTI R, Scaggiante F, Falciani M, Weichenberger CX, et al
    Prevalence and determinants of serum antibodies to SARS-CoV-2 in the general population of the Gardena valley.
    Epidemiol Infect. 2021;149:e194.
    >> Share

  213. KELLY G, Petti S, Noah N
    Covid-19, non-Covid-19 and excess mortality rates not comparable across countries.
    Epidemiol Infect. 2021;149:e176.
    >> Share

  214. ALVES JD, Abade AS, Peres WP, Borges JE, et al
    Impact of COVID-19 on the indigenous population of Brazil: a geo-epidemiological study.
    Epidemiol Infect. 2021;149:e185.
    >> Share

    July 2021
  215. OTTAVIANO E, Parodi C, Borghi E, Massa V, et al
    Saliva detection of SARS-CoV-2 for mitigating company outbreaks: a surveillance experience, Milan, Italy, March 2021.
    Epidemiol Infect. 2021;149:e171.
    >> Share

  216. YI B, Poetsch AR, Stadtmuller M, Rost F, et al
    Phylogenetic analysis of SARS-CoV-2 lineage development across the first and second waves in Eastern Germany in 2020: insights into the cause of the second wave.
    Epidemiol Infect. 2021;149:e177.
    >> Share

  217. CARLTON LH, Chen T, Whitcombe AL, McGregor R, et al
    Charting elimination in the pandemic: a SARS-CoV-2 serosurvey of blood donors in New Zealand.
    Epidemiol Infect. 2021;149:e173.
    >> Share

  218. YAMADA G, Hayakawa K, Matsunaga N, Terada M, et al
    Predicting respiratory failure for COVID-19 patients in Japan: a simple clinical score for evaluating the need for hospitalisation.
    Epidemiol Infect. 2021;149:e175.
    >> Share

  219. BREWER TF, Zhang M, Gordon D, Chung RY, et al
    Housing, sanitation and living conditions affecting SARS-CoV-2 prevention interventions in 54 African countries.
    Epidemiol Infect. 2021;149:e183.
    >> Share

  220. YAKOB L
    Isolation thresholds for curbing SARS-CoV-2 resurgence.
    Epidemiol Infect. 2021;149:e168.
    >> Share

  221. THOMAS BS, Marks NA
    Estimating the case fatality ratio for COVID-19 using a time-shifted distribution analysis.
    Epidemiol Infect. 2021;149:e197.
    >> Share

  222. BOENDER TS, Bender JK, Kruger A, Michaelis K, et al
    Factors preventing SARS-CoV-2 transmission during unintentional exposure in a GP practice: a cohort study of patient contacts; Germany, 2020.
    Epidemiol Infect. 2021;149:e161.
    >> Share

  223. AKHMETZHANOV AR
    Estimation of delay-adjusted all-cause excess mortality in the USA: March-December 2020.
    Epidemiol Infect. 2021;149:e156.
    >> Share

  224. DITE GS, Murphy NM, Allman R
    Development and validation of a clinical and genetic model for predicting risk of severe COVID-19.
    Epidemiol Infect. 2021;149:e162.
    >> Share

  225. MUSA OAH, Chivese T, Bansal D, Abdulmajeed J, et al
    Prevalence and determinants of symptomatic COVID-19 infection among children and adolescents in Qatar: a cross-sectional analysis of 11 445 individuals.
    Epidemiol Infect. 2021;149:e193.
    >> Share

    June 2021
  226. CARDENAS VM
    RE: George et al. 'High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond?'
    Epidemiol Infect. 2021;149:e151.
    >> Share

  227. GEORGE CE, Inbaraj LR
    Re: George et al. High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond?
    Epidemiol Infect. 2021;149:e152.
    >> Share

  228. GOZLAN Y, Reingold S, Koren R, Halpern O, et al
    SARS-CoV-2 outbreak in a synagogue community: longevity and strength of anti-SARS-CoV-2 IgG responses.
    Epidemiol Infect. 2021;149:e153.
    >> Share

  229. WOUDENBERG T, Eberle U, Marosevic D, Liebl B, et al
    Detection and viral RNA shedding of SARS-CoV-2 in respiratory specimens relative to symptom onset among COVID-19 patients in Bavaria, Germany.
    Epidemiol Infect. 2021;149:e150.
    >> Share

  230. ZHANG R, Gao Y, Xie D, Lian R, et al
    Characteristics of systematic reviews evaluating treatments for COVID-19 registered in PROSPERO.
    Epidemiol Infect. 2021;149:e146.
    >> Share

  231. MALDONADO MD, Romero-Aibar J, Perez-San-Gregorio MA
    COVID-19 pandemic as a risk factor for the reactivation of herpes viruses.
    Epidemiol Infect. 2021;149:e145.
    >> Share

  232. DE MARCO VERISSIMO C, O'Brien C, Lopez Corrales J, Dorey A, et al
    Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests.
    Epidemiol Infect. 2021;149:e140.
    >> Share

  233. GUVEN BB, Erturk T, Kompe O, Ersoy A, et al
    Serious complications in COVID-19 ARDS cases: pneumothorax, pneumomediastinum, subcutaneous emphysema and haemothorax.
    Epidemiol Infect. 2021;149:e137.
    >> Share

    May 2021
  234. IMPOUMA B, Mlanda T, Bukhari A, Sie Williams G, et al
    Information management practices in the WHO African Region to support response to the COVID-19 pandemic.
    Epidemiol Infect. 2021;149:e260.
    >> Share

  235. JAIN J, Saurabh S, Kumar P, Verma MK, et al
    COVID-19 vaccine hesitancy among medical students in India.
    Epidemiol Infect. 2021;149:e132.
    >> Share

  236. MCDONALD SA, van den Wijngaard CC, Wielders CCH, Friesema IHM, et al
    Risk factors associated with the incidence of self-reported COVID-19-like illness: data from a web-based syndromic surveillance system in the Netherlands.
    Epidemiol Infect. 2021;149:e129.
    >> Share

  237. DE SOUZA ARAUJO AA, Quintans-Junior LJ, Heimfarth L, Schimieguel DM, et al
    Seroprevalence of SARS-CoV-2 antibodies in the poorest region of Brazil: results from a population-based study.
    Epidemiol Infect. 2021;149:e130.
    >> Share

  238. HAMMER CC, Cristea V, Dub T, Sivela J, et al
    High but slightly declining COVID-19 vaccine acceptance and reasons for vaccine acceptance, Finland April to December 2020.
    Epidemiol Infect. 2021;149:e123.
    >> Share

  239. IMPOUMA B, Mboussou F, Wolfe CM, Farham B, et al
    COVID-19 in the WHO African region: using risk assessment to inform decisions on public health and social measures.
    Epidemiol Infect. 2021;149:e259.
    >> Share

    April 2021
  240. MAJUMDAR P, Niyogi S
    SARS-CoV-2 mutations: the biological trackway towards viral fitness.
    Epidemiol Infect. 2021;149:e110.
    >> Share

  241. CRUZ EHM, Maciel JM, Clozato CL, Serpa MS, et al
    Simulation-based evaluation of school reopening strategies during COVID-19: A case study of Sao Paulo, Brazil.
    Epidemiol Infect. 2021;149:e118.
    >> Share

  242. ZHAO S, Yang Z, Musa SS, Ran J, et al
    Attach importance of the bootstrap t test against Student's t test in clinical epidemiology: a demonstrative comparison using COVID-19 as an example.
    Epidemiol Infect. 2021;149:e107.
    >> Share

  243. VERA-ZERTUCHE JM, Mancilla-Galindo J, Tlalpa-Prisco M, Aguilar-Alonso P, et al
    Obesity is a strong risk factor for short-term mortality and adverse outcomes in Mexican patients with COVID-19: a national observational study.
    Epidemiol Infect. 2021;149:e109.
    >> Share

  244. MOUSSA R, Majdalani S
    Use of the Hayami diffusive wave equation to model the relationship infected-recoveries-deaths of Covid-19 pandemic.
    Epidemiol Infect. 2021;149:e138.
    >> Share

  245. SHARIF N, Ahmed SN, Opu RR, Daullah MU, et al
    Impact of meteorological parameters and population density on variants of SARS-CoV-2 and outcome of COVID-19 pandemic in Japan.
    Epidemiol Infect. 2021;149:e103.
    >> Share

  246. KIM SH, Kim YJ, Jeong YJ, Park JH, et al
    Construction of a non-contact community treatment centre for asymptomatic and mildly symptomatic COVID-19 patients during the COVID-19 pandemic.
    Epidemiol Infect. 2021;149:e111.
    >> Share

  247. LOPEZ-CHEDA A, Jacome MA, Cao R, De Salazar PM, et al
    Estimating lengths-of-stay of hospitalised COVID-19 patients using a non-parametric model: a case study in Galicia (Spain).
    Epidemiol Infect. 2021;149:e102.
    >> Share

  248. KSHATRI JS, Bhattacharya D, Praharaj I, Mansingh A, et al
    Seroprevalence of SARS-CoV-2 in Bhubaneswar, India: findings from three rounds of community surveys.
    Epidemiol Infect. 2021;149:e139.
    >> Share

  249. ALLEN N, Riain UN, Conlon N, Ferenczi A, et al
    Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers.
    Epidemiol Infect. 2021;149:e157.
    >> Share

  250. DRESSLER A, Finci I, Wagner-Wiening C, Eichner M, et al
    Epidemiological analysis of 3,219 COVID-19 outbreaks in the state of Baden-Wuerttemberg, Germany.
    Epidemiol Infect. 2021;149:e101.
    >> Share

  251. BAGGIO JAO, Machado MF, Carmo RFD, Armstrong ADC, et al
    COVID-19 in Brazil: spatial risk, social vulnerability, human development, clinical manifestations and predictors of mortality - a retrospective study with data from 59 695 individuals.
    Epidemiol Infect. 2021;149:e100.
    >> Share

  252. LUO S, Xin M, Wang S, Zhao J, et al
    Behavioural intention of receiving COVID-19 vaccination, social media exposures and peer discussions in China.
    Epidemiol Infect. 2021;149:e158.
    >> Share

  253. ZARE F, Teimouri M, Khosravi A, Rohani-Rasaf M, et al
    COVID-19 re-infection in Shahroud, Iran: a follow-up study.
    Epidemiol Infect. 2021;149:e159.
    >> Share

  254. MARCO A, Gallego C, Perez-Caceres V, Guerrero RA, et al
    Public health response to an outbreak of SARS-CoV2 infection in a Barcelona prison.
    Epidemiol Infect. 2021;149:e91.
    >> Share

  255. KARIMZADEH S, Bhopal R, Nguyen Tien H
    Review of infective dose, routes of transmission and outcome of COVID-19 caused by the SARS-COV-2: comparison with other respiratory viruses.
    Epidemiol Infect. 2021;149:e96.
    >> Share

  256. IMPOUMA B, Wolfe CM, Mboussou F, Farham B, et al
    Monitoring and evaluation of COVID-19 response in the WHO African region: challenges and lessons learned.
    Epidemiol Infect. 2021;149:e98.
    >> Share

  257. HU HY, Yan F, Zhu JM, Karuno AP, et al
    Intercontinental transmission and local demographic expansion of SARS-CoV-2.
    Epidemiol Infect. 2021;149:e94.
    >> Share

  258. MOETI M
    Leadership, collaboration and using data science to fight COVID-19 in the WHO African region.
    Epidemiol Infect. 2021;149:e262.
    >> Share

  259. SEMENZA JC, Adlhoch C, Baka A, Broberg E, et al
    COVID-19 research priorities for non-pharmaceutical public health and social measures.
    Epidemiol Infect. 2021;149:e87.
    >> Share

  260. MASSAD E, Amaku M, Tadeu Covas D, Fernandes Lopez L, et al
    Estimating the effects of reopening of schools on the course of the epidemic of COVID-19.
    Epidemiol Infect. 2021;149:e86.
    >> Share

  261. MAO Y, Tan YR, Thein TL, Chai YAL, et al
    Identifying COVID-19 cases in outpatient settings.
    Epidemiol Infect. 2021;149:e92.
    >> Share

    March 2021
  262. WANG K, Wang X, Du J, Liu C, et al
    Relationship between changes in the course of COVID-19 and ratio of neutrophils-to-lymphocytes and related parameters in patients with severe vs. common disease.
    Epidemiol Infect. 2021;149:e81.
    >> Share

  263. MUKHERJEE A, Anand T, Agarwal A, Singh H, et al
    SARS-CoV-2 re-infection: development of an epidemiological definition from India.
    Epidemiol Infect. 2021;149:e82.
    >> Share

  264. BLANCO N, Stafford KA, Lavoie MC, Brandenburg A, et al
    A simple model for the total number of SARS-CoV-2 infections on a national level.
    Epidemiol Infect. 2021;149:e80.
    >> Share

  265. GALLO O, Peris A, Trotta M, Orlando P, et al
    Epidemiological analysis of a COVID-19 outbreak associated with an infected surgeon.
    Epidemiol Infect. 2021;149:e77.
    >> Share

  266. OGIMI C, Qu P, Boeckh M, Bender Ignacio RA, et al
    Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis.
    Epidemiol Infect. 2021;149:e75.
    >> Share

  267. KUCHENHOFF H, Gunther F, Hohle M, Bender A, et al
    Analysis of the early COVID-19 epidemic curve in Germany by regression models with change points.
    Epidemiol Infect. 2021;149:e68.
    >> Share

  268. KOZER E, Rinott E, Kozer G, Bar-Haim A, et al
    Presence of SARS-CoV-2 RNA on playground surfaces and water fountains.
    Epidemiol Infect. 2021;149:e67.
    >> Share

  269. ELSON R, Davies TM, Lake IR, Vivancos R, et al
    The spatio-temporal distribution of COVID-19 infection in England between January and June 2020.
    Epidemiol Infect. 2021;149:e73.
    >> Share

  270. TAKEFUJI Y
    Fourier analysis using the number of COVID-19 daily deaths in the US.
    Epidemiol Infect. 2021;149:e64.
    >> Share

  271. BOHM S, Woudenberg T, Chen D, Marosevic DV, et al
    Epidemiology and transmission characteristics of early COVID-19 cases, 20 January-19 March 2020, in Bavaria, Germany.
    Epidemiol Infect. 2021;149:e65.
    >> Share

    February 2021
  272. CASTRO RR, Santos RSC, Sousa GJB, Pinheiro YT, et al
    Spatial dynamics of the COVID-19 pandemic in Brazil.
    Epidemiol Infect. 2021;149:e60.
    >> Share

  273. MICHOS A, Savvidou P, Syridou G, Eleftheriou E, et al
    SARS-CoV-2 molecular testing in Greek hospital paediatric departments: a nationwide study.
    Epidemiol Infect. 2021;149:e70.
    >> Share

  274. CHENG A, Chen Y, Gao Y, Sun P, et al
    Mobile isolation wards in a fever clinic: a novel operation model during the COVID-19 pandemic.
    Epidemiol Infect. 2021;149:e61.
    >> Share

  275. HONG K, Yum SJ, Kim JH, Chun BC, et al
    Re-estimation of basic reproduction number of COVID-19 based on the epidemic curve by symptom onset date.
    Epidemiol Infect. 2021;149:e53.
    >> Share

  276. DUQUE MP, Lucaccioni H, Costa C, Marques R, et al
    COVID-19 symptoms: a case-control study, Portugal, March-April 2020.
    Epidemiol Infect. 2021;149:e54.
    >> Share

  277. LEHMANN J, Giesinger JM, Rumpold G, Borena W, et al
    Estimating seroprevalence of SARS-CoV-2 antibodies using three self-reported symptoms: development of a prediction model based on data from Ischgl, Austria.
    Epidemiol Infect. 2021;149:e52.
    >> Share

  278. ZHAO K, Ai L, Zhao Y, Wang T, et al
    Diagnostic value of using a combination of nucleic acid and specific antibody tests for SARS-CoV-2 in coronavirus disease 2019.
    Epidemiol Infect. 2021;149:e62.
    >> Share

  279. LELIS DA SILVA F, Dias Pita J, Gomes MDA, Lelis da Silva AP, et al
    Intraregional propagation of Covid-19 cases in Para, Brazil: assessment of isolation regime to lockdown.
    Epidemiol Infect. 2021;149:e72.
    >> Share

  280. GAO Y, Chen Y, Liu M, Niu M, et al
    Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis.
    Epidemiol Infect. 2021;149:e66.
    >> Share

  281. MIYAMA T, Iritani N, Nishio T, Ukai T, et al
    Seasonal shift in epidemics of respiratory syncytial virus infection in Japan.
    Epidemiol Infect. 2021;149:e55.
    >> Share

  282. AI J, Shi N, Shi Y, Xu K, et al
    Epidemiologic characteristics and influencing factors of cluster infection of COVID-19 in Jiangsu Province.
    Epidemiol Infect. 2021;149:e48.
    >> Share

  283. SHANG C, Yang Y, Chen GY, Shang XD, et al
    A simple transmission dynamics model for predicting the evolution of COVID-19 under control measures in China.
    Epidemiol Infect. 2021;149:e43.
    >> Share

  284. BAILIE CR, Franklin L, Nicholson S, Mordant F, et al
    Symptoms and laboratory manifestations of mild COVID-19 in a repatriated cruise ship cohort.
    Epidemiol Infect. 2021;149:e44.
    >> Share

  285. WEIBELZAHL S, Reiter J, Duden G
    Depression and anxiety in healthcare professionals during the COVID-19 pandemic.
    Epidemiol Infect. 2021;149:e46.
    >> Share

  286. GEORGE CE, Inbaraj LR, Chandrasingh S, de Witte LP, et al
    High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond?
    Epidemiol Infect. 2021;149:e39.
    >> Share

  287. KAMAR A, Maalouf N, Hitti E, El Eid G, et al
    Challenge of forecasting demand of medical resources and supplies during a pandemic: A comparative evaluation of three surge calculators for COVID-19.
    Epidemiol Infect. 2021;149:e51.
    >> Share

  288. SINGH RKS, Malik MZ, Singh RKB
    Diversity of SARS-CoV-2 isolates driven by pressure and health index.
    Epidemiol Infect. 2021;149:e38.
    >> Share

    January 2021
  289. PETT J, McAleavey P, McGurnaghan P, Spiers R, et al
    Epidemiology of COVID-19 in Northern Ireland, 26 February 2020-26 April 2020.
    Epidemiol Infect. 2021;149:e36.
    >> Share

  290. PRANATA R, Lim MA, Yonas E, Huang I, et al
    Thrombocytopenia as a prognostic marker in COVID-19 patients: diagnostic test accuracy meta-analysis.
    Epidemiol Infect. 2021;149:e40.
    >> Share

  291. ZAVASCKI AP
    Urgent need for evaluation of point-of-care tests as an RT-PCR-sparing strategy for the diagnosis of Covid-19 in symptomatic patients.
    Epidemiol Infect. 2021;149:e35.
    >> Share

  292. CHOW WK, Chow CL
    Response to Letter to Editor by Zavascki A.P.: Urgent need for evaluating point-of-care tests as a RT-PCR-sparing strategy for the diagnosis of Covid-19 in symptomatic patients.
    Epidemiol Infect. 2021;149:e33.
    >> Share

  293. WANG Y, Luo H, Liu S, Hao T, et al
    Respiratory failure among patients with COVID-19 in Jiangsu province, China: a multicentre retrospective cohort study.
    Epidemiol Infect. 2021;149:e31.
    >> Share

  294. SETHI SM, Ahmed AS, Hanif S, Aqeel M, et al
    Subcutaneous emphysema and pneumomediastinum in patients with COVID-19 disease; case series from a tertiary care hospital in Pakistan.
    Epidemiol Infect. 2021;149:e37.
    >> Share

  295. VENTURELLI S, Benatti SV, Casati M, Binda F, et al
    Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation.
    Epidemiol Infect. 2021;149:e32.
    >> Share

  296. WENG CH, Saal A, McGuire DC, Chan PA, et al
    Persistently high SARS-CoV-2 positivity rate and incidence for Hispanic/Latinos during state reopening in an urban setting: a retrospective cohort study.
    Epidemiol Infect. 2021;149:e25.
    >> Share

  297. LE TD, Bosworth M, Ledlow G, Le TT, et al
    Influences of reopening businesses and social venues: COVID-19 incidence rate in East Texas county.
    Epidemiol Infect. 2021;149:e28.
    >> Share

  298. WEI J, Guo S, Long E, Zhang L, et al
    Why does the spread of COVID-19 vary greatly in different countries? Revealing the efficacy of face masks in epidemic prevention.
    Epidemiol Infect. 2021;149:e24.
    >> Share

  299. ISHIKAWA G, Argenti G, Fadel CB
    Non-specific blood tests as proxies for COVID-19 hospitalisation: are there plausible associations after excluding noisy predictors?
    Epidemiol Infect. 2021;149:e23.
    >> Share

  300. LI W, Gong J, Zhou J, Zhang L, et al
    An evaluation of COVID-19 transmission control in Wenzhou using a modified SEIR model.
    Epidemiol Infect. 2021;149:e2.
    >> Share

  301. GE Y, Sun S, Shen Y
    Estimation of case-fatality rate in COVID-19 patients with hypertension and diabetes mellitus in the New York state: a preliminary report.
    Epidemiol Infect. 2021;149:e14.
    >> Share

  302. SALMON RL, Monaghan SP
    Who is dying from COVID-19 in the United Kingdom? A review of cremation authorisations from a single South Wales' crematorium.
    Epidemiol Infect. 2021;149:e13.
    >> Share

  303. SHARIF N, Dey SK
    Impact of population density and weather on COVID-19 pandemic and SARS-CoV-2 mutation frequency in Bangladesh.
    Epidemiol Infect. 2021;149:e16.
    >> Share

  304. LIU Y, Haussinger L, Steinacker JM, Dinse-Lambracht A, et al
    Association between the dynamics of the COVID-19 epidemic and ABO blood type distribution.
    Epidemiol Infect. 2021;149:e19.
    >> Share

  305. ILESANMI OS, Afolabi AA, Akande A, Raji T, et al
    Infection prevention and control during COVID-19 pandemic: realities from health care workers in a north central state in Nigeria.
    Epidemiol Infect. 2021;149:e15.
    >> Share

  306. WEI ZY, Qiao R, Chen J, Huang J, et al
    The influence of pre-existing hypertension on coronavirus disease 2019 patients.
    Epidemiol Infect. 2021;149:e4.
    >> Share

  307. LIANG C, Shen L
    An analysis of coronavirus disease 2019 with spline regression at province level during first-level response to major public health emergency out of Hubei, China.
    Epidemiol Infect. 2021;149:e10.
    >> Share

  308. CHOW WK, Chow CL
    A discussion on implementing pooling detection tests of novel coronavirus (SARS-CoV-2) for a large population.
    Epidemiol Infect. 2021;149:e17.
    >> Share

  309. DENG L, Zhang J, Wang M, Chen L, et al
    Obesity is associated with severe COVID-19 but not death: a dose-response meta-analysis.
    Epidemiol Infect. 2021;149:e144.
    >> Share

    December 2020
  310. WEI C, Lee CC, Hsu TC, Hsu WT, et al
    Correlation of population mortality of COVID-19 and testing coverage: a comparison among 36 OECD countries.
    Epidemiol Infect. 2020;149:e1.
    >> Share

  311. FERNANDEZ-SALINAS J, Aragon-Caqueo D, Valdes G, Laroze D, et al
    Modelling pool testing for SARS-CoV-2: addressing heterogeneity in populations.
    Epidemiol Infect. 2020;149:e9.
    >> Share

  312. YANG J, Ma Z, Lei Y
    A meta-analysis of the association between obesity and COVID-19.
    Epidemiol Infect. 2020;149:e11.
    >> Share

  313. ARINO J, Bajeux N, Portet S, Watmough J, et al
    Quarantine and the risk of COVID-19 importation.
    Epidemiol Infect. 2020;148:e298.
    >> Share

  314. YUNG CF, Saffari E, Liew C
    Time to Rt < 1 for COVID-19 public health lockdown measures.
    Epidemiol Infect. 2020;148:e301.
    >> Share

  315. YOUNG BE, Mak TM, Ang LW, Sadarangani S, et al
    Influenza vaccine failure in the tropics: a retrospective cohort study of waning effectiveness.
    Epidemiol Infect. 2020 Dec 2:1-29. doi: 10.1017/S0950268820002952.
    >> Share

  316. DE ALMEIDA GB, Pronunciate M, Grotto RMT, Azevedo Pugliesi E, et al
    Two hundred days of COVID-19 in Sao Paulo State, Brazil.
    Epidemiol Infect. 2020;148:e295.
    >> Share

  317. ANDRADE LA, Gomes DS, Lima SVMA, Duque AM, et al
    COVID-19 mortality in an area of northeast Brazil: epidemiological characteristics and prospective spatiotemporal modelling.
    Epidemiol Infect. 2020;148:e288.
    >> Share

  318. MO P, Deng L, Liu X, Gao S, et al
    Risk factors for delayed negative conversion of SARS-CoV-2 in patients with COVID-19 pneumonia: a retrospective cohort study.
    Epidemiol Infect. 2020;148:e293.
    >> Share

    November 2020
  319. MANCILLA-GALINDO J, Vera-Zertuche JM, Navarro-Cruz AR, Segura-Badilla O, et al
    Development and validation of the patient history COVID-19 (PH-Covid19) scoring system: a multivariable prediction model of death in Mexican patients with COVID-19.
    Epidemiol Infect. 2020;148:e286.
    >> Share

  320. THOMPSON JV, Meghani NJ, Powell BM, Newell I, et al
    Patient characteristics and predictors of mortality in 470 adults admitted to a district general hospital in England with Covid-19.
    Epidemiol Infect. 2020;148:e285.
    >> Share

  321. CAO Y, Wang Y, Das A, Pan CQ, et al
    Transmission dynamics of COVID-19 among index case family clusters in Beijing, China.
    Epidemiol Infect. 2020;149:e74.
    >> Share

  322. HABONIMANA D, Ouedraogo L, Ndirahisha E, Misago N, et al
    Understanding the influence of the COVID-19 pandemic on hospital-based mortality in Burundi: a cross-sectional study comparing two time periods.
    Epidemiol Infect. 2020;148:e280.
    >> Share

  323. SANTAMARIA L, Hortal J
    Chasing the ghost of infection past: identifying thresholds of change during the COVID-19 infection in Spain.
    Epidemiol Infect. 2020;148:e282.
    >> Share

  324. SUNG J, Choudry N, Bachour R
    Development and validation of a simple risk score for diagnosing COVID-19 in the emergency room.
    Epidemiol Infect. 2020;148:e273.
    >> Share

  325. SULYOK M, Walker M
    Community movement and COVID-19: a global study using Google's Community Mobility Reports.
    Epidemiol Infect. 2020;148:e284.
    >> Share

  326. SHAKIBA M, Nazemipour M, Heidarzadeh A, Mansournia MA, et al
    Prevalence of asymptomatic COVID-19 infection using a seroepidemiological survey.
    Epidemiol Infect. 2020;148:e300.
    >> Share

  327. KAZANCIOGLU S, Bastug A, Ozbay BO, Kemirtlek N, et al
    The Role of Hematological Parameters in Patients with Coronavirus Disease 2019 and Influenza Virus Infection.
    Epidemiol Infect. 2020 Nov 5:1-16. doi: 10.1017/S095026882000271.
    >> Share

  328. GREBE G, Velez JA, Tiutiunnyk A, Aragon-Caqueo D, et al
    Dynamic quarantine: a comparative analysis of the Chilean public health response to COVID-19.
    Epidemiol Infect. 2020;148:e270.
    >> Share

  329. GURSAKAL N, Batmaz B, Aktuna G
    Drawing transmission graphs for COVID-19 in the perspective of network science.
    Epidemiol Infect. 2020;148:e269.
    >> Share

    October 2020
  330. ISLAM MZ, Riaz BK, Islam ANMS, Khanam F, et al
    Risk factors associated with morbidity and mortality outcomes of COVID-19 patients on the 28th day of the disease course: a retrospective cohort study in Bangladesh.
    Epidemiol Infect. 2020;148:e263.
    >> Share

  331. RIVERA R, Rosenbaum JE, Quispe W
    Excess mortality in the United States during the first three months of the COVID-19 pandemic.
    Epidemiol Infect. 2020;148:e264.
    >> Share

  332. MAJUMDAR P, Niyogi S
    ORF3a mutation associated with higher mortality rate in SARS-CoV-2 infection.
    Epidemiol Infect. 2020;148:e262.
    >> Share

  333. MEIKSIN A
    Dynamics of COVID-19 transmission including indirect transmission mechanisms: a mathematical analysis.
    Epidemiol Infect. 2020;148:e257.
    >> Share

  334. ZHANG SX, Graf-Vlachy L, Looi KH, Su R, et al
    Social media use as a predictor of handwashing during a pandemic: evidence from COVID-19 in Malaysia.
    Epidemiol Infect. 2020;148:e261.
    >> Share

  335. ZENG L, Wang S, Cai J, Sun S, et al
    Clinical characteristics of COVID-19 with cardiac injury: a systematic review and meta-analysis.
    Epidemiol Infect. 2020;148:e266.
    >> Share

  336. DE SALAZAR PM, Gomez-Barroso D, Pampaka D, Gil JM, et al
    Lockdown measures and relative changes in the age-specific incidence of SARS-CoV-2 in Spain.
    Epidemiol Infect. 2020;148:e268.
    >> Share

  337. LI X, Marmar T, Xu Q, Tu J, et al
    Predictive indicators of severe COVID-19 independent of comorbidities and advanced age: a nested case-control study.
    Epidemiol Infect. 2020;148:e255.
    >> Share

  338. BRANDL M, Selb R, Seidl-Pillmeier S, Marosevic D, et al
    Mass gathering events and undetected transmission of SARS-CoV-2 in vulnerable populations leading to an outbreak with high case fatality ratio in the district of Tirschenreuth, Germany.
    Epidemiol Infect. 2020;148:e252.
    >> Share

  339. TEIXEIRA R, Doetsch J
    The multifaceted role of mobile technologies as a strategy to combat COVID-19 pandemic.
    Epidemiol Infect. 2020;148:e244.
    >> Share

  340. TAKAYA S, Tsuzuki S, Hayakawa K, Kawashima A, et al
    Nightlife clusters of coronavirus disease in Tokyo between March and April 2020.
    Epidemiol Infect. 2020;148:e250.
    >> Share

  341. GOODALL JW, Reed TAN, Ardissino M, Bassett P, et al
    Risk factors for severe disease in patients admitted with COVID-19 to a hospital in London, England: a retrospective cohort study.
    Epidemiol Infect. 2020;148:e251.
    >> Share

  342. KHAN ZS, Van Bussel F, Hussain F
    A predictive model for Covid-19 spread - with application to eight US states and how to end the pandemic.
    Epidemiol Infect. 2020;148:e249.
    >> Share

  343. SIFF EJ, Aghagoli G, Gallo Marin B, Tobin-Tyler E, et al
    SARS-CoV-2 transmission: a sociological review.
    Epidemiol Infect. 2020;148:e242.
    >> Share

  344. WANG Y, Xu C, Yao S, Zhao Y, et al
    Forecasting the epidemiological trends of COVID-19 prevalence and mortality using the advanced alpha-Sutte Indicator.
    Epidemiol Infect. 2020;148:e236.
    >> Share

  345. GUO J, Zhou B, Zhu M, Yuan Y, et al
    CURB-65 may serve as a useful prognostic marker in COVID-19 patients within Wuhan, China: a retrospective cohort study.
    Epidemiol Infect. 2020;148:e241.
    >> Share

    September 2020
  346. SHI P, Ren G, Yang J, Li Z, et al
    Clinical characteristics of imported and second-generation coronavirus disease 2019 (COVID-19) cases in Shaanxi outside Wuhan, China: a multicentre retrospective study.
    Epidemiol Infect. 2020;148:e238.
    >> Share

  347. SINGH D, Joshi K, Samuel A, Patra J, et al
    Alcohol-based hand sanitisers as first line of defence against SARS-CoV-2: a review of biology, chemistry and formulations.
    Epidemiol Infect. 2020;148:e229.
    >> Share

  348. LOPEZ-ABENTE J, Valor-Suarez C, Lopez-Abente G
    Massive application of the SARS-CoV-2 diagnostic test: simulation of its effect on the evolution of the epidemic in Spain.
    Epidemiol Infect. 2020;148:e233.
    >> Share

  349. FERNANDES DE, Ferreira PRA, Mastroianni Kirsztajn G
    Pre-exposure prophylaxis during the SARS-CoV-2 pandemic: can PrEP prevent COVID-19-related symptoms?
    Epidemiol Infect. 2020;148:e231.
    >> Share

  350. GUBENSEK J, Vajdic Trampuz B, Persic V, Gregorcic S, et al
    The possibility of SARS-CoV-2 transmission in a haemodialysis unit - report from a large in-hospital centre.
    Epidemiol Infect. 2020;148:e226.
    >> Share

  351. SARASWATHI S, Mukhopadhyay A, Shah H, Ranganath TS, et al
    Social network analysis of COVID-19 transmission in Karnataka, India.
    Epidemiol Infect. 2020;148:e230.
    >> Share

  352. ZONGO P, Zorom M, Mophou G, Dorville R, et al
    A model of COVID-19 transmission to understand the effectiveness of the containment measures: application to data from France.
    Epidemiol Infect. 2020;148:e221.
    >> Share

  353. CHEEMA S, Ameduri M, Abraham A, Doraiswamy S, et al
    The COVID-19 pandemic: the public health reality.
    Epidemiol Infect. 2020;148:e223.
    >> Share

  354. CHEN M, Wei X, Wang Z
    Protecting healthcare workers from SARS-CoV-2 and other infections.
    Epidemiol Infect. 2020;148:e217.
    >> Share

  355. AHMAD I, Muhammad Asad S
    Predictions of coronavirus COVID-19 distinct cases in Pakistan through an artificial neural network.
    Epidemiol Infect. 2020;148:e222.
    >> Share

  356. CHEN LZ, Lin ZH, Chen J, Liu SS, et al
    Can elevated concentrations of ALT and AST predict the risk of 'recurrence' of COVID-19?
    Epidemiol Infect. 2020;148:e218.
    >> Share

  357. SONG W, Sawafta FJ, Ebrahem BM, Jebril MA, et al
    Public attitude towards quarantine during the COVID-19 outbreak.
    Epidemiol Infect. 2020;148:e220.
    >> Share

  358. DUAN P, Deng ZQ, Pan ZY, Wang YP, et al
    Safety considerations during return to work in the context of stable COVID-19 epidemic control: an analysis of health screening results of all returned staff from a hospital.
    Epidemiol Infect. 2020;148:e214.
    >> Share

  359. HAW NJL, Uy J, Sy KTL, Abrigo MRM, et al
    Epidemiological profile and transmission dynamics of COVID-19 in the Philippines.
    Epidemiol Infect. 2020;148:e204.
    >> Share

  360. TINTO B, Salinas S, Dicko A, Kagone TS, et al
    Spreading of SARS-CoV-2 in West Africa and assessment of risk factors.
    Epidemiol Infect. 2020;148:e213.
    >> Share

  361. ELIMIAN KO, Ochu CL, Ilori E, Oladejo J, et al
    Descriptive epidemiology of coronavirus disease 2019 in Nigeria, 27 February-6 June 2020.
    Epidemiol Infect. 2020;148:e208.
    >> Share

  362. BISWAS RK, Afiaz A, Huq S
    Underreporting COVID-19: the curious case of the Indian subcontinent.
    Epidemiol Infect. 2020;148:e207.
    >> Share

  363. WANG X, Li X, Shang Y, Wang J, et al
    Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with coronavirus disease 2019 (COVID-19): a retrospective cohort study in a single medical centre.
    Epidemiol Infect. 2020;148:e211.
    >> Share

  364. HAIDER N, Yavlinsky A, Chang YM, Hasan MN, et al
    The Global Health Security index and Joint External Evaluation score for health preparedness are not correlated with countries' COVID-19 detection response time and mortality outcome.
    Epidemiol Infect. 2020;148:e210.
    >> Share

  365. GAYAWAN E, Awe OO, Oseni BM, Uzochukwu IC, et al
    The spatio-temporal epidemic dynamics of COVID-19 outbreak in Africa.
    Epidemiol Infect. 2020;148:e212.
    >> Share

    August 2020
  366. LAI R, Chen E, Gao W, Cheng C, et al
    Sentinel surveillance strategies for early detection of coronavirus disease in fever clinics: experience from China.
    Epidemiol Infect. 2020;148:e205.
    >> Share

  367. LANARI M, Anderson EJ, Sheridan-Pereira M, Carbonell-Estrany X, et al
    Burden of respiratory syncytial virus hospitalisation among infants born at 32-35 weeks' gestational age in the Northern Hemisphere: pooled analysis of seven studies.
    Epidemiol Infect. 2020;148:e170.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016